December 1, 2025 /
Marketing
Stay informed with MS news and information - Sign-up here
For MS patients, caregivers or clinicians, Care to chat about MS? Join Our online COMMUNITY CHAT
Categories
Latest Blog Posts
- Press Release : Sanofi provides update on tolebrutinib regulatory submission in non-relapsing secondary progressive multiple sclerosis
- A Request from YOUR MS Peer, asking you to HELP us (MS Views and News) Make an Impact! 💙
- What is the Best Diet for MS, by Aaron Boster, MD
- video: Optic Neuritis MRI Orbits Findings
- video: Remyelination in MS
- video: Curious about early MS symptoms doctors often miss?
- video: SMALL IMPROVEMENTS Matter
- video: Multiple Sclerosis Progression, Independent from relapse Activity
- Living with MS: Sometimes One Really Is the Loneliest Number
- MOGAD has unique immune signature distinct from MS: Study
- FDA approves generic version of Vumerity for relapsing MS
- New Biological Mechanism Boosts Myelin Production in the Brain
- 4 Vitamin B12 Deficiency Symptoms You Need to Know
- Sandoz launches TYRUKO® (natalizumab-sztn) in US, as first and only multiple sclerosis biosimilar
- Genentech’s Fenebrutinib Shows Unprecedented Positive Phase III Results as the Potential First and Only BTK Inhibitor in Both Relapsing and Primary Progressive Multiple Sclerosis
- UIC Study: Remote Pilates Program for People Living with MS
- Exercise and Cognition in Multiple Sclerosis in 2025: Forward Momentum or Going Nowhere Fast?
- Safety, adherence, and compliance in a RCT of supervised exercise training among persons with multiple sclerosis who have slowed cognitive processing speed
- Trigeminal neuralgia and MS
- What Is an MS Zinger and How Can You Manage It?
